- 期刊
- OpenAccess
Peroxisome Proliferator-Activated Receptor Delta Agonists and AMP-Activated Protein Kinase Activators Reverse Interleukin 6-Inhibited Erythropoietin Receptor Expression
摘要
BACKGROUND: Interleukin-6 (IL-6) was shown to inhibit erythropoietin receptor (EpoR) expression in erythroid progenitor cells. The anti-inflammatory effects of peroxisome proliferator-activated receptor (PPAR) agonists and AMP-activated protein kinase (AMPK) activators have been proven in previous studies. This study is going to evaluate the effects of PPAR agonists and AMPK activators on IL-6- induced inhibition of EpoR expression and possible mechanisms. METHODS: Human erythroleukemia cells (K562) were incubated with IL-6 (5 ng/mL) for 18 hours in the presence and then absence of an AMPK activator HybriMore (200 μM) and peroxisome proliferatoractivated receptor δ (PPARδ) agonists L-165,041 (1 μM). The expression of EpoR and two downstream substances of AMPK, phosphorylated acetyl-CoA carboxylase (ACC), and glycogen synthase kinase (GSK) in K562 cells was measured. RESULTS: IL-6 significantly inhibited EpoR expression in K562 cells. HybriMore (200 μM) and L-165,041 (1 μM) significantly reversed IL-6 induced inhibition of EpoR expression with similar potency. IL-6 also significantly inhibited phosphorylated glycogen synthase kinase 3 (GSK3) and ACC expression. HybriMore showed no effect on IL-6-induced inhibition of phosphorylated GSK3 and ACC. L-165,041, however, reversed the inhibition of ACC, but had no effect on GSK3. CONCLUSION: Both PPAR agonists and AMPK activators significantly reverse IL-6-inhibited EpoR expression in K562 cells. The effect of AMPK activators may have no relationship with ACC or GSK3.
延伸閱讀
- Gbaguidi, G. C., Copin, C., Derudas, B., Marx, N., Eechkoute, J., & Staels, B. (2016). Peroxisome Proliferator-Activated Receptor γ Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages. PPAR Research, 2016(), 47-55. https://doi.org/10.1155/2016/2756781
- Lee, D. L., Wilson, J. L., Duan, R., Hudson, T., & Marakby, A. E. (2011). Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension. PPAR Research, 2011(), 120-126. https://doi.org/10.1155/2011/502631
- Sheng, X., Zhang, Y., Gong, Z., Huang, C., & Zang, Y. Q. (2008). Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors. PPAR Research, 2008(), 826-834-078. https://doi.org/10.1155/2008/581348
- Peng, Y., Li, Q., Zhang, L., Bai, M., & Zhang, Z. (2012). Peroxisome Proliferator-Activated Receptor α Plays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury. PPAR Research, 2012(), 888-894. https://doi.org/10.1155/2012/970525
- Mansour, M. M., Goyal, H. O., Braden, T. D., Dennis, J. C., Schwartz, D. D., Judd, R. L., Bartol, F. F., Coleman, E. S., & Morrison, E. E. (2008). Activation of Penile Proadipogenic Peroxisome Proliferator-Activated Receptor γ with an Estrogen: Interaction with Estrogen Receptor Alpha during Postnatal Development. PPAR Research, 2008(), 882-891-086. https://doi.org/10.1155/2008/651419